A headache is a common type of pain that many people experience. It can occur on one or both sides of the head, range from mild to severe and can last anywhere from a few minutes to several days. Headaches can be caused by a variety of things, including stress, illness or injury, changes in sleeping patterns, dehydration, or overuse of certain medications. They can also be caused by tension in the muscles of the neck, face or scalp, as well as being a side effect of certain medical conditions, such as a sinus infection or a migraine. Treatment for a headache depends on the underlying cause. In some cases, over-the-counter pain relievers such as ibuprofen or aspirin may help to reduce symptoms. If the headaches are caused by tension, relaxation techniques such as yoga or massage can be beneficial. If the headaches are due to an underlying medical condition, treatment should address that condition. When a headache is recurrent, persistent or severe, it is important to visit a doctor to identify any potential problems. The doctor will review your medical history and conduct a physical exam to help diagnose the cause of the headache. Treatment may then be recommended, including medication, lifestyle changes, or referral to a specialist. Headaches can be disruptive, but there are steps you can take to help reduce the frequency and severity of the symptoms. Keeping a headache diary, avoiding triggers, and developing a healthy sleeping pattern can all help make headaches more manageable. Additionally, eating a balanced diet, staying hydrated, and practicing relaxation techniques such as deep breathing or visualization can be beneficial.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States